SARS-CoV-2 S B.1.617.2 delta variant + S2M11 + S2L20 Global Refinement
Resolution: 2.4 Å
EM Method: Single-particle
Fitted PDBs: 7so9
Q-score: 0.6
McCallum M, Walls AC, Sprouse KR, Bowen JE, Rosen LE, Dang HV, De Marco A, Franko N, Tilles SW, Logue J, Miranda MC, Ahlrichs M, Carter L, Snell G, Pizzuto MS, Chu HY, Van Voorhis WC, Corti D, Veesler D
Science (2021) 374 pp. 1621-1626 [ DOI: doi:10.1126/science.abl8506 Pubmed: 34751595 ]
- 2-acetamido-2-deoxy-beta-d-glucopyranose (221 Da, Ligand)
- S2l20 fab light chain (11 kDa, Protein from Homo sapiens)
- S2l20 fab heavy chain (13 kDa, Protein from Homo sapiens)
- Spike glycoprotein (141 kDa, Protein from Severe acute respiratory syndrome coronavirus 2)
- Sars-cov-2 s b.1.617.2 delta variant + s2m11 fab + s2l20 fab (Complex from Severe acute respiratory syndrome coronavirus 2)
- S2m11 fab light chain (11 kDa, Protein from Homo sapiens)
- Water (18 Da, Ligand)
- S2m11 fab heavy chain (13 kDa, Protein from Homo sapiens)
SARS-CoV-2 S NTD B.1.617.2 delta variant + S2L20 Local Refinement
Resolution: 3.1 Å
EM Method: Single-particle
Fitted PDBs: 7soa
Q-score: 0.553
McCallum M, Walls AC, Sprouse KR, Bowen JE, Rosen LE, Dang HV, De Marco A, Franko N, Tilles SW, Logue J, Miranda MC, Ahlrichs M, Carter L, Snell G, Pizzuto MS, Chu HY, Van Voorhis WC, Corti D, Veesler D
Science (2021) 374 pp. 1621-1626 [ DOI: doi:10.1126/science.abl8506 Pubmed: 34751595 ]
- 2-acetamido-2-deoxy-beta-d-glucopyranose (221 Da, Ligand)
- S2l20 fab light chain (11 kDa, Protein from Homo sapiens)
- S2l20 fab heavy chain (13 kDa, Protein from Homo sapiens)
- Sars-cov-2 s ntd b.1.617.2 delta variant + s2l20 fab (Complex from Severe acute respiratory syndrome coronavirus 2)
- Spike glycoprotein (141 kDa, Protein from Severe acute respiratory syndrome coronavirus 2)
SARS-CoV-2 S B.1.617.1 kappa variant + S309 + S2L20 Global Refinement
Resolution: 2.4 Å
EM Method: Single-particle
Fitted PDBs: 7sob
Q-score: 0.483
McCallum M, Walls AC, Sprouse KR, Bowen JE, Rosen LE, Dang HV, De Marco A, Franko N, Tilles SW, Logue J, Miranda MC, Ahlrichs M, Carter L, Snell G, Pizzuto MS, Chu HY, Van Voorhis WC, Corti D, Veesler D
Science (2021) 374 pp. 1621-1626 [ DOI: doi:10.1126/science.abl8506 Pubmed: 34751595 ]
- Spike glycoprotein (141 kDa, Protein from Severe acute respiratory syndrome coronavirus 2)
- 2-acetamido-2-deoxy-beta-d-glucopyranose (221 Da, Ligand)
- S309 fab heavy chain (14 kDa, Protein from Homo sapiens)
- Sars-cov-2 s b.1.617.1 kappa variant + s309 fab + s2l20 fab (Complex from Severe acute respiratory syndrome coronavirus 2)
- S2l20 fab heavy chain (13 kDa, Protein from Homo sapiens)
- S309 fab light chain (10 kDa, Protein from Homo sapiens)
- S2l20 fab light chain (11 kDa, Protein from Homo sapiens)
- Water (18 Da, Ligand)
SARS-CoV-2 S RBD B.1.617.1 kappa variant S309 Local Refinement
Resolution: 3.3 Å
EM Method: Single-particle
Fitted PDBs: 7soc
Q-score: 0.541
McCallum M, Walls AC, Sprouse KR, Bowen JE, Rosen LE, Dang HV, De Marco A, Franko N, Tilles SW, Logue J, Miranda MC, Ahlrichs M, Carter L, Snell G, Pizzuto MS, Chu HY, Van Voorhis WC, Corti D, Veesler D
Science (2021) 374 pp. 1621-1626 [ DOI: doi:10.1126/science.abl8506 Pubmed: 34751595 ]
- Spike glycoprotein (141 kDa, Protein from Severe acute respiratory syndrome coronavirus 2)
- 2-acetamido-2-deoxy-beta-d-glucopyranose (221 Da, Ligand)
- S309 fab light chain (11 kDa, Protein from Homo sapiens)
- Sars-cov-2 s rbd b.1.617.1 kappa variant + s309 fab (Complex from Severe acute respiratory syndrome coronavirus 2)
- S309 fab heavy chain (14 kDa, Protein from Homo sapiens)
SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement
Resolution: 3.2 Å
EM Method: Single-particle
Fitted PDBs: 7sod
Q-score: 0.551
McCallum M, Walls AC, Sprouse KR, Bowen JE, Rosen LE, Dang HV, De Marco A, Franko N, Tilles SW, Logue J, Miranda MC, Ahlrichs M, Carter L, Snell G, Pizzuto MS, Chu HY, Van Voorhis WC, Corti D, Veesler D
Science (2021) 374 pp. 1621-1626 [ DOI: doi:10.1126/science.abl8506 Pubmed: 34751595 ]
- Spike glycoprotein (141 kDa, Protein from Severe acute respiratory syndrome coronavirus 2)
- 2-acetamido-2-deoxy-beta-d-glucopyranose (221 Da, Ligand)
- S2l20 fab light chain (11 kDa, Protein from Homo sapiens)
- S2l20 fab heavy chain (13 kDa, Protein from Homo sapiens)
- Sars-cov-2 s ntd b.1.617.1 kappa variant + s2l20 fab (Complex from Severe acute respiratory syndrome coronavirus 2)
SARS-CoV-2 S B.1.617.1 kappa variant + S2X303 Global Refinement
Resolution: 2.8 Å
EM Method: Single-particle
Fitted PDBs: 7soe
Q-score: 0.452
McCallum M, Walls AC, Sprouse KR, Bowen JE, Rosen LE, Dang HV, De Marco A, Franko N, Tilles SW, Logue J, Miranda MC, Ahlrichs M, Carter L, Snell G, Pizzuto MS, Chu HY, Van Voorhis WC, Corti D, Veesler D
Science (2021) 374 pp. 1621-1626 [ DOI: doi:10.1126/science.abl8506 Pubmed: 34751595 ]
- Spike glycoprotein (141 kDa, Protein from Severe acute respiratory syndrome coronavirus 2)
- 2-acetamido-2-deoxy-beta-d-glucopyranose (221 Da, Ligand)
- S2x303 fab light chain (11 kDa, Protein from Homo sapiens)
- S2x303 fab heavy chain (13 kDa, Protein from Homo sapiens)
- Sars-cov-2 s b.1.617.1 kappa variant + s2x303 fab (Complex from Severe acute respiratory syndrome coronavirus 2)
SARS-CoV-2 S NTD B.1.617.1 kappa variant S2X303 Local Refinement
Resolution: 3.6 Å
EM Method: Single-particle
Fitted PDBs: 7sof
Q-score: 0.461
McCallum M, Walls AC, Sprouse KR, Bowen JE, Rosen LE, Dang HV, De Marco A, Franko N, Tilles SW, Logue J, Miranda MC, Ahlrichs M, Carter L, Snell G, Pizzuto MS, Chu HY, Van Voorhis WC, Corti D, Veesler D
Science (2021) 374 pp. 1621-1626 [ DOI: doi:10.1126/science.abl8506 Pubmed: 34751595 ]
- Sars-cov-2 s ntd b.1.617.1 kappa variant + s2x303 fab (Complex from Severe acute respiratory syndrome coronavirus 2)
- Spike glycoprotein (141 kDa, Protein from Severe acute respiratory syndrome coronavirus 2)
- 2-acetamido-2-deoxy-beta-d-glucopyranose (221 Da, Ligand)
- S2x303 fab light chain (11 kDa, Protein from Homo sapiens)
- S2x303 fab heavy chain (13 kDa, Protein from Homo sapiens)
Boyoglu-Barnum S, Ellis D, Gillespie RA, Hutchinson GB, Park YJ, Moin SM, Acton OJ, Ravichandran R, Murphy M, Pettie D, Matheson N, Carter L, Creanga A, Watson MJ, Kephart S, Ataca S, Vaile JR, Ueda G, Crank MC, Stewart L, Lee KK, Guttman M, Baker D, Mascola JR, Veesler D, Graham BS, King NP, Kanekiyo M
Nature (2021) 592 pp. 623-628 [ Pubmed: 33762730 DOI: doi:10.1038/s41586-021-03365-x ]
Boyoglu-Barnum S, Ellis D, Gillespie RA, Hutchinson GB, Park YJ, Moin SM, Acton OJ, Ravichandran R, Murphy M, Pettie D, Matheson N, Carter L, Creanga A, Watson MJ, Kephart S, Ataca S, Vaile JR, Ueda G, Crank MC, Stewart L, Lee KK, Guttman M, Baker D, Mascola JR, Veesler D, Graham BS, King NP, Kanekiyo M
Nature (2021) 592 pp. 623-628 [ Pubmed: 33762730 DOI: doi:10.1038/s41586-021-03365-x ]
Boyoglu-Barnum S, Ellis D, Gillespie RA, Hutchinson GB, Park YJ, Moin SM, Acton OJ, Ravichandran R, Murphy M, Pettie D, Matheson N, Carter L, Creanga A, Watson MJ, Kephart S, Ataca S, Vaile JR, Ueda G, Crank MC, Stewart L, Lee KK, Guttman M, Baker D, Mascola JR, Veesler D, Graham BS, King NP, Kanekiyo M
Nature (2021) 592 pp. 623-628 [ Pubmed: 33762730 DOI: doi:10.1038/s41586-021-03365-x ]